Shafer Health Strategies brings expert-led clinical discussions directly to community providers — surfacing real-world intelligence that pharma, biotech, and diagnostic teams can act on.
Emily founded SHS to bridge the gap between the clinical insights pharmaceutical and biotech teams need and the community providers who hold them. With deep expertise in medical affairs, scientific communications, and KOL engagement, she brings a hands-on, strategy-first approach to every engagement.
SHS is a medical affairs and scientific communications consultancy that partners with pharmaceutical, biotech, and academic organizations to elevate the quality, clarity, and impact of scientific exchange. We specialize in transforming complex clinical and scientific data into strategic, evidence-based communications that drive informed decision-making, clinician engagement, and improved patient care.
To empower life science organizations to advance evidence-based medicine through strategic, scientifically rigorous, and ethically grounded communication — transforming complex data into clear, impactful insights that elevate clinician education, strengthen scientific exchange, and improve patient outcomes.
Hyper-local, curated discussions where a KOL leads six community providers in focused, insight-rich dialogue — surfacing clinical decision drivers, barriers to adoption, competitive landscape insights, and the practical realities of community practice.
Full execution from recruiting oncologists and coordinating KOL participation to concierge-level logistics, discussion guide development, and actionable insights reports. Your team stays on strategy — we handle the rest.
Designed for efficient replication across regions and therapeutic areas. Each forum generates its own insight report, building an expanding library of community-level intelligence that compounds over time.
Beyond Clinical Exchange Forums, SHS provides end-to-end support across the medical communications ecosystem — blending scientific rigor, strategic thinking, and operational precision. All work meets GPP, ICMJE, OIG, and ACPE standards.
| Clinical Exchange Forum | Traditional Advisory Board | |
|---|---|---|
| Primary purpose | Peer-to-peer clinical discussion that surfaces real-world insights | Structured feedback to inform company strategy |
| Discussion style | Conversational, clinician-driven, KOL-moderated | Formal, company-driven Q&A |
| Participants | Hard-to-reach community providers | Highly engaged experts and known advisors |
| Logistics | Hyper-local, evening timing, transportation provided | Centralized location, requires travel |
| Insight type | Raw, practical, community-level barriers and behaviors | High-level strategic insights from established experts |
| Relationship impact | Opens new engagement funnel with previously unreachable providers | Deepens relationship with already-engaged KOLs |
Most advisory models center on academic hubs and known experts. SHS was built around the insight gap — the 90% of care that happens in the community, from providers who rarely get asked what they think.
Clinical Exchange Forums create an ongoing flywheel — building lasting relationships, not one-off events.
SHS maintains strict procedural, operational, and technological firewalls to ensure complete independence between accredited CME activities and any commercial or promotional services. All work is conducted under governance structures fully aligned with ACCME Standards for Integrity and Independence.
Tell us about your education and insights goals. We'll design a Clinical Exchange Forum program tailored to your therapeutic area, target markets, and strategic objectives.